Detalles de la búsqueda
1.
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
Lancet
; 403(10426): 533-544, 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310910
2.
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
Lancet Oncol
; 24(12): 1321-1333, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37949086
3.
VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study.
Clin Infect Dis
; 76(7): 1304-1310, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36358012
4.
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
Lancet
; 397(10287): 1809-1818, 2021 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33964223
5.
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffii.
Biotechnol Bioeng
; 119(2): 657-662, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34780057
6.
Comparative genomics of whole-cell pertussis vaccine strains from India.
BMC Genomics
; 21(1): 345, 2020 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32381023
7.
Development and validation of magnetic bead pentaplex immunoassay for simultaneous quantification of murine serum IgG antibodies to acellular pertussis, diphtheria and tetanus antigens used in combination vaccines.
Methods
; 158: 33-43, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30690077
8.
The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation.
Lancet
; 402(10412): 1507-1510, 2023 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37683681
9.
Complete structural elucidation of an oxidized polysialic acid drug intermediate by nuclear magnetic resonance spectroscopy.
Bioconjug Chem
; 25(4): 665-76, 2014 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24679150
10.
Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases.
Vaccines (Basel)
; 12(4)2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38675815
11.
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Hum Vaccin Immunother
; 20(1): 2304974, 2024 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38512394
12.
Development and validation of capillary electrophoresis sodium dodecyl sulfate (CE-SDS) method for purity analysis of pertussis toxin, filamentous haemagglutinin and pertactin antigens.
Vaccine
; 41(40): 5854-5862, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37591705
13.
A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India.
Vaccine X
; 14: 100300, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37128477
14.
A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
Vaccine X
; 14: 100313, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37234594
15.
Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactin.
Front Immunol
; 14: 1190404, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37342321
16.
Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast.
Vaccines (Basel)
; 11(10)2023 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897004
17.
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany.
Vaccine
; 2023 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37827966
18.
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies.
J Pharm Sci
; 112(2): 458-470, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36462710
19.
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative Combinations.
J Pharm Sci
; 112(2): 446-457, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36096284
20.
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India.
Expert Rev Vaccines
; 22(1): 278-287, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883291